Navigation Links
New electronic health records demonstration project 'encouraging step' says ACP
Date:11/1/2007

ormation technology (HIT) to support quality improvement activities by:
  • developing and adopting national standards; and
  • providing initial financial support and ongoing reimbursement incentives for physicians in smaller practices.

Increased use of HIT could greatly benefit health care in the U.S. through improved patient care, reduction in medical errors, higher efficiency, and potential long-run cost savings, concluded Dr. Dale. However, in order for patients to see any of these benefits we need to ensure that their physicians are able to acquire these important technologies.


'/>"/>

Contact: David Kinsman
dkinsman@acponline.org
202-261-4554
American College of Physicians
Source:Eurekalert

0

GOOD

Page: 1 2

Related medicine news :

1. Electronic nose by Italian scientists
2. Stem Cells Could Replace Electronic Pacemakers
3. Electronic Skin (E-Skin) To Robots
4. $ 1.7 Million NYSTAR Award for Binghamton University to Flex Electronics Research Muscle.
5. Electronic Device to the Rescue of Women Using Contraceptive Pill
6. Solitons Could Power Molecular Electronics, Artificial Muscles
7. Electronic Patient Record "Serious Threat" to Patient Confidentiality
8. Electronic Medical Record For Every American by 2014
9. PM promises forward-looking IT, electronics policy soon
10. HL7 Announces Industry’s First Electronic Health Record System (EHR-S
11. Electronic Nerve Stimulator Enables Walking
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 2China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 3China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 4China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 5China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 6China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 7China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 8OrBIT Study Long Term Results Show Sustained Therapeutic Effect of Percutaneous Tibial Nerve Stimulation at 12 Months 2OrBIT Study Long Term Results Show Sustained Therapeutic Effect of Percutaneous Tibial Nerve Stimulation at 12 Months 3OrBIT Study Long Term Results Show Sustained Therapeutic Effect of Percutaneous Tibial Nerve Stimulation at 12 Months 4Brain difference in psychopaths identified 9468 1Brain difference in psychopaths identified 9468 2Ferring Pharmaceuticals Announces Trade Name FIRMAGON 28R 29 28degarelix for injection 29 for Advanced Prostate Cancer Treatment 53625 1Ferring Pharmaceuticals Announces Trade Name FIRMAGON 28R 29 28degarelix for injection 29 for Advanced Prostate Cancer Treatment 53625 2Ferring Pharmaceuticals Announces Trade Name FIRMAGON 28R 29 28degarelix for injection 29 for Advanced Prostate Cancer Treatment 53625 3Ferring Pharmaceuticals Announces Trade Name FIRMAGON 28R 29 28degarelix for injection 29 for Advanced Prostate Cancer Treatment 53625 4Office of National Drug Control Policy Taps RIESTER creative for Use in National Anti Meth Campaign 53622 1Office of National Drug Control Policy Taps RIESTER creative for Use in National Anti Meth Campaign 53622 2